PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurgical Innovations Regulatory News (SUN)

Share Price Information for Surgical Innovations (SUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.50
Bid: 0.40
Ask: 0.60
Change: 0.00 (0.00%)
Spread: 0.20 (50.00%)
Open: 0.50
High: 0.50
Low: 0.50
Prev. Close: 0.50
SUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Successful exhibition at ISHA in the US

11 Oct 2012 07:00

RNS Number : 4345O
Surgical Innovations Group PLC
11 October 2012
 



Surgical Innovations Group plc

("SI" or the "Company")

 

Successful exhibition at ISHA in the US

 

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of creative solutions for minimally invasive surgery ('MIS'), announces a successful ISHA (International Society of Hip Arthroscopy) exhibition last week in Boston, MA where the Company's pre-production hip arthroscopy products were well-received by surgeons from across the globe.

 

The Company said it was encouraging to see how its portfolio of laparoscopic instrumentation can successfully transfer to the arthroscopy market giving surgeons improved access, safety and visualisation during surgical procedures.

 

The technology and IP used in SI's port access system and retraction devices created substantial interest from the international surgeons, with many keen to work with the Company to develop the prototypes further and offer clinical feedback over the coming months.

 

The consensus amongst surgeons was that new innovative instrumentation was needed in the hip arthroscopic market to respond to the growing development of the specialism, something which SI is ideally placed to provide. The feedback from the congress has also highlighted new product opportunities that will ultimately increase the effectiveness and safety of the procedure itself.

 

Graham Bowland, CEO of SI said: "It was promising to see the high number and international diversity of surgeons in attendance at ISHA. It is clear there is a passion to drive forward the hip arthroscopy discipline as a key method of treatment for various forms of hip repair. We believe the technology transfer from our laparoscopic instrumentation into hip arthroscopy is well-placed to overcome the challenges hip arthroscopy specialists are facing, and with our in-house design and manufacture teams, SI can rapidly bring innovative products through from concept to ultimate clinical use. SI is proud to be a part of this exciting new surgical discipline."

 

Leading UK hip arthroscopy surgeon, Sion Glyn Jones, said: "The market of hip arthroscopy has already demonstrated an exponential rise in the UK (450%), statistics that were presented at the British Osteopathic Association (BOA) earlier in the year. Over the next few years this rise is expected to continue as improvements in technology are made, more surgeons adopt hip arthroscopy practices and patient demand increases. It is arguably the most rapidly growing field in orthopedic surgery."

 

Surgical Innovations Group plc

www.sigroupplc.com

Graham Bowland, Chief Executive Officer

Tel: +44 (0) 113 230 7597

 

 

Seymour Pierce Limited

www.seymourpierce.com

Mark Percy (Corporate Finance)

Tel: +44 (0) 20 7107 8000

David Banks (Corporate Broking)

 

 

 

Walbrook PR Ltd

Tel: +44 (0) 20 7933 8780

Paul McManus

Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com

Lianne Cawthorne

Mob: 07584 391 303 or lianne.cawthorne@walbrookpr.com

 

 

Notes to Editors:

 

About Surgical Innovations Group plc

 

Surgical Innovations Group plc specialises in the design and manufacture of creative solutions for minimally invasive surgery (MIS) and industrial markets.

 

As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.

 

Over 120 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.

 

The Group's patented products are sold through three main channels:

 

SI brand

Through an established network of distribution partners, Surgical Innovations branded products are sold in major medical markets including North America, Britain, South East Asia, Australasia and the Indian subcontinent.

 

OEM and IP

The Group supplies large medical device companies on an OEM basis, generating both sales and IP royalty fees. Clients include Teleflex Medical, Olympus and CareFusion.

 

Industrial

 

SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, in situ with minimum disassembly and downtime.

 

For more information, see www.sigrouplplc.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAKEEFLPAFFF
Date   Source Headline
1st Sep 20117:00 amRNSRe Agreement
1st Sep 20117:00 amRNSAgreement with Surgical Innovations Group
24th Aug 20117:00 amRNSNotice of Results
22nd Jul 20117:00 amRNSRe Agreement
20th Jun 20112:42 pmRNSResult of AGM
20th Jun 20117:00 amRNSAGM Statement
13th Jun 20115:08 pmRNSHolding(s) in Company
11th May 20115:12 pmRNSIssue of Equity
3rd May 20114:05 pmRNSIssue of Equity
26th Apr 20114:34 pmRNSDirector/PDMR Shareholding
21st Apr 201111:47 amRNSHolding(s) in Company
19th Apr 20117:00 amRNSFinal Results
28th Mar 201112:04 pmRNSHolding(s) in Company
24th Mar 201112:17 pmRNSHolding(s) in Company
24th Feb 20113:40 pmRNSHolding(s) in Company
15th Feb 20114:45 pmRNSExercise of Options
14th Feb 20117:00 amRNSRe Contract
14th Jan 201110:08 amRNSTrading Statement
1st Dec 20107:00 amRNSChange of Adviser
29th Oct 201012:11 pmRNSTotal Voting Rights
27th Oct 20102:32 pmPRNDirector/PDMR Shareholding
13th Oct 20103:04 pmPRNIssue of Equity
8th Oct 20103:31 pmPRNDirector/PDMR Shareholding
5th Oct 20102:38 pmRNSHolding(s) in Company
30th Sep 20107:00 amRNSTotal Voting Rights
24th Sep 20107:00 amRNSIssue of Equity
14th Sep 20102:09 pmRNSTR-1: Notification of Major Interest in Shares
14th Sep 20107:00 amRNSHalf Yearly Report
24th Aug 20107:00 amRNSNotice of Results
28th Jul 20107:00 amRNSFDA approval for device
16th Jul 20101:20 pmRNSCourt Approval
4th Jun 20102:12 pmRNSDirector/PDMR Shareholding
28th May 20102:26 pmRNSHolding(s) in Company
28th May 20107:00 amRNSFive year contract with Teleflex Medical
25th May 20102:10 pmRNSResult of AGM
25th May 20107:00 amRNSAGM Statement
17th May 20104:20 pmPRNHolding(s) in Company
17th May 20107:00 amRNSMajor industrial order delivered
28th Apr 20103:41 pmRNSPosting of Annual Report and Accounts
21st Apr 20107:00 amRNSSI wins Queen's Award for Enterprise
9th Apr 20102:54 pmPRNDirector/PDMR Shareholding
31st Mar 20107:00 amRNSPreliminary Results
4th Mar 201012:50 pmPRNHolding(s) in Company
22nd Jan 20103:36 pmPRNDirector/PDMR Shareholding
20th Jan 20107:00 amRNSNotice of Results
18th Jan 20107:00 amRNSContract win with US Group Purchasing Organisation
14th Dec 20097:00 amRNSEntry into veterinary market
2nd Dec 200911:13 amPRNHolding(s) in Company
17th Nov 20099:55 amPRNHolding(s) in Company
13th Nov 20092:10 pmPRNDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.